A Single Center, Randomized, Open-label, Cross-over Exploratory Study to Evaluate the Pharmacodynamic and Pharmacokinetic Response to a Subcutaneous Administration or Oral Administration of Furosemide in Subjects With Heart Failure Presenting With Chronic Fluid Overload

Trial Profile

A Single Center, Randomized, Open-label, Cross-over Exploratory Study to Evaluate the Pharmacodynamic and Pharmacokinetic Response to a Subcutaneous Administration or Oral Administration of Furosemide in Subjects With Heart Failure Presenting With Chronic Fluid Overload

Completed
Phase of Trial: Phase I/II

Latest Information Update: 23 Aug 2015

At a glance

  • Drugs Furosemide (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms FUROPHARM-HF; scFUROPHARM
  • Sponsors scPharmaceuticals
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 14 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top